Securinine derivatives as potential anti-amyloid therapeutic approach
dc.creator | Neganova M.E. | |
dc.creator | Klochkov S.G. | |
dc.creator | Petrova L.N. | |
dc.creator | Shevtsova E.F. | |
dc.creator | Afanasieva S.V. | |
dc.creator | Chudinova E.S. | |
dc.creator | Fisenko V.P. | |
dc.creator | Bachurin S.O. | |
dc.creator | Barreto G.E. | |
dc.creator | Aliev G. | |
dc.date.accessioned | 2020-09-02T22:24:17Z | |
dc.date.accessioned | 2022-11-08T20:20:38Z | |
dc.date.available | 2020-09-02T22:24:17Z | |
dc.date.available | 2022-11-08T20:20:38Z | |
dc.date.created | 2020-09-02T22:24:17Z | |
dc.date.issued | 2017 | |
dc.identifier | 16, 3, 351-355 | |
dc.identifier | 18715273 | |
dc.identifier | https://hdl.handle.net/20.500.12728/5564 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5143681 | |
dc.language | en | |
dc.publisher | Bentham Science Publishers B.V. | |
dc.subject | Alkaloids | |
dc.subject | Antioxidant | |
dc.subject | Lipid peroxidation | |
dc.subject | Neurodegenerative diseases | |
dc.subject | Neuroprotection | |
dc.subject | Securinine | |
dc.subject | β-amyloid | |
dc.subject | amyloid beta protein | |
dc.subject | antioxidant | |
dc.subject | securinine | |
dc.subject | amyloid beta protein | |
dc.subject | amyloid beta-protein (1-42) | |
dc.subject | antioxidant | |
dc.subject | azepine derivative | |
dc.subject | fused heterocyclic rings | |
dc.subject | lactone | |
dc.subject | peptide fragment | |
dc.subject | piperidine derivative | |
dc.subject | securinine | |
dc.subject | animal experiment | |
dc.subject | antioxidant activity | |
dc.subject | Article | |
dc.subject | degenerative disease | |
dc.subject | fluorescence analysis | |
dc.subject | high performance liquid chromatography | |
dc.subject | IC50 | |
dc.subject | lipid peroxidation | |
dc.subject | male | |
dc.subject | nonhuman | |
dc.subject | nuclear magnetic resonance spectroscopy | |
dc.subject | oxidative stress | |
dc.subject | rat | |
dc.subject | Alzheimer disease | |
dc.subject | amyloidosis | |
dc.subject | animal | |
dc.subject | chemistry | |
dc.subject | drug effect | |
dc.subject | human | |
dc.subject | metabolism | |
dc.subject | oxidative stress | |
dc.subject | Alzheimer Disease | |
dc.subject | Amyloid beta-Peptides | |
dc.subject | Amyloidosis | |
dc.subject | Animals | |
dc.subject | Antioxidants | |
dc.subject | Azepines | |
dc.subject | Heterocyclic Compounds, Bridged-Ring | |
dc.subject | Humans | |
dc.subject | Lactones | |
dc.subject | Male | |
dc.subject | Oxidative Stress | |
dc.subject | Peptide Fragments | |
dc.subject | Piperidines | |
dc.subject | Rats | |
dc.title | Securinine derivatives as potential anti-amyloid therapeutic approach | |
dc.type | Article |